Karyopharm Therapeutics To Webcast Investor & Analyst Briefing On Monday, June 2, 2014
NATICK, Mass., May 30, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, invites investors and the general public to listen to a webcast of its Investor & Analyst Briefing on Monday, June 2 at 6:15 PM Central Time. At this briefing, Karyopharm's management team will provide a clinical update in conjunction with the 2014 American Society of Clinical Oncology (ASCO) annual meeting.
Help employers find you! Check out all the jobs and post your resume.